Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis

被引:28
作者
Ng, Cheng Han [1 ]
Ong, Zhi Hao [1 ]
Sran, Hersharan Kaur [1 ,2 ]
Wee, Teo Boon [1 ,2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, 10 Med Dr, Singapore 117597, Singapore
[2] Natl Univ Singapore Hosp, Univ Med Cluster, Div Nephrol, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore
关键词
Meta-analysis; End-stage kidney disease; Cardiovascular disease; Mortality; Dialysis; STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; SURVIVAL ADVANTAGE; META-REGRESSION; OUTCOMES; RATES; METAANALYSIS; MODALITY; TRANSPLANTATION;
D O I
10.1007/s11255-020-02683-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose Cardiovascular disease is a significant cause of morbidity and mortality in dialysis patients. With the increasing prevalence of dialysis patients, there is a need to systematically identify the epidemiology of cardiovascular disease in hemodialysis and peritoneal dialysis patients. Methods A meta-analysis was conducted in reference to the MOOSE and PRISMA guidelines. Database searches were conducted on Medline and Embase on 17 March 2020. Meta-analysis of proportions was used to summarize the overall prevalence of events. Pairwise comparisons were used to compare between hemodialysis and peritoneal dialysis, and meta-regression was applied to identify the factors influencing disease. Results A total of 28 studies were included in the review and prevalence of cardiovascular disease events including coronary artery disease, coronary artery complications, congestive heart failure, peripheral arterial disease, atrial fibrillation, and cardiovascular mortality were summarized. Atrial fibrillation (RR 1.287 CI 1.154-1.436, p < 0.001), congestive heart failure (RR 1.229 CI 1.074-1.407, p = 0.003), and peripheral arterial disease (RR 1.132 CI 1.021-1.255, p = 0.019) were more common in hemodialysis patients, but cardiovascular mortality was lower in hemodialysis relative to peritoneal dialysis patients. (RR 0.892 CI 0.828-0.960, p = 0.002). Conclusion The authors have found fewer cardiovascular events but higher cardiovascular mortality in patients on PD as compared to those on HD. Future research is required to establish the causality between dialysis modality and the cardiovascular outcomes described.
引用
收藏
页码:1363 / 1371
页数:9
相关论文
共 62 条
[1]   Atrial Fibrillation Characteristics in Patients on Haemodialysis vs. Peritoneal Dialysis [J].
Abuhasira, Ran ;
Mizrakli, Yuval ;
Shimony, Avi ;
Novack, Victor ;
Shnaider, Alla ;
Haviv, Yosef S. .
SCIENTIFIC REPORTS, 2018, 8
[2]   Immune cell dysfunction and inflammation in end-stage renal disease [J].
Betjes, Michiel G. H. .
NATURE REVIEWS NEPHROLOGY, 2013, 9 (05) :255-265
[3]   The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease [J].
Borras Sans, Mercs ;
Perez-Fontan, Miguel ;
Martinez-Alonso, Montserrat ;
Bajo, Auxiliadora ;
Betriu, Angels ;
Valdivielso, Jose A. M. ;
Fernandez, Elvira .
PLOS ONE, 2017, 12 (11)
[4]   Access flow reduction for cardiac failure [J].
Bourquelot, Pierre .
JOURNAL OF VASCULAR ACCESS, 2016, 17 :S60-S63
[5]   Hemodialysis Leads to Better Survival in Patients with Diabetes or High Comorbidity, Compared to Peritoneal Dialysis [J].
Chang, Jae Hyun ;
Sung, Ji Yoon ;
Ahn, Shin Young ;
Ko, Kwang-Pil ;
Ro, Han ;
Jung, Ji Yong ;
Lee, Hyun Hee ;
Chung, Wookyung ;
Kim, Sejoong .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 229 (04) :271-277
[6]   Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis [J].
Chang, Tara I-Hsin ;
Liu, Sai ;
Airy, Medha ;
Niu, Jingbo ;
Turakhia, Mintu P. ;
Flythe, Jennifer E. ;
Montez-Rath, Maria E. ;
Winkelmayer, Wolfgang C. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07) :1029-1038
[7]   Comparative study of renal replacement therapy in Korean diabetic end-stage renal disease patients: a single center study [J].
Choi, SR ;
Lee, SC ;
Kim, BS ;
Yoon, SY ;
Park, HC ;
Kang, SW ;
Choi, KH ;
Kim, YS ;
Ha, SK ;
Park, K ;
Han, DS ;
Lee, HY .
YONSEI MEDICAL JOURNAL, 2003, 44 (03) :454-462
[8]   Mortality risks of peritoneal dialysis and hemodialysis [J].
Collins, AJ ;
Hao, WL ;
Xia, H ;
Ebben, JP ;
Everson, SE ;
Constantini, EG ;
Ma, JZ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1065-1074
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model [J].
Doi, Suhail A. R. ;
Barendregt, Jan J. ;
Khan, Shahjahan ;
Thalib, Lukman ;
Williams, Gail M. .
CONTEMPORARY CLINICAL TRIALS, 2015, 45 :130-138